Skip to main content
OpenTrials
Completed

NCT Number: NCT04190537

PARADOX - the Incidence of Paradoxical Reactions in Pediatric Patients Premedicated with Midazolam

Summary

The premedication is one of the essential sides of pediatrics anesthesia. Midazolam is considered such as standard these days. Children may develope a paradoxical reaction to benzodiazepines which is one of the adverse effect. Its incidence is unknown. The hypothesis is, in pediatric patients undergoing general anesthesia premedicated with oral midazolam, the incidence of the paradoxical reaction is 10%. Primary Goal of the study is to find out the incidence of the paradoxical reaction in pediatric patients premedicated with oral midazolam prior to general anesthesia. Secondary goal is to find out the incidence of the paradoxical reactions in children of different age groups. For the assessment, the study uses parameters: RASS, blood pressure, heart rate, PAED, PSAS, MAS and VAS.

Completed

Looking for future studies?

Notify Me

Key information

Age range

3 month–18 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Masaryk hospital

Ústí nad Labem, 40011, Czechia

About this study

The premedication is one of the essential sides of pediatrics anesthesia. Midazolam is considered such as standard these days. Children may develope a paradoxical reaction to benzodiazepines which is one of the adverse effect.

The paradoxical reaction is an abnormal stimulative reaction to benzodiazepines characterized by hallucination, disorientation, alteration in perception and recognition as well as the escalation of negative emotion- uncalming crying, agitation, restlessness, and hostility. Risk factors for the development of the paradoxical reaction are young age, mental illness, genetic disposition, male sex, alcohol abuse, and higher midazolam doses.

The incidence of paradoxical reaction is referred to be about 1-10%, in some specific groups even more (about 29%). The exact incidence is still not known since the accurate definition of paradoxical reaction is still missing.

Primary Goal of the study is find out the incidence of the paradoxical reaction in pediatric patients premedicated with oral midazolam prior to general anesthesia and incidence of the paradoxical reactions in children of different age groups (3 months-1 year, 1 year-3 years, 3 years-6 years, 6 years-12 years, 12 years-18 years) . The calculated file size is 500 patients. All eligible patients should be evaluated for pre-treatment, pre-anesthesia, immediately prior to anesthesia and anesthesia when RASS above -2. For purpose of the study we have determined the definition of paradoxical reaction as an increase in pulse and/or blood pressure of 20% over pre-premedication , RASS increase by one point or more and raising PEAD to 10 or more points. The paradoxical reaction criteria are met if at least two points of the definition are met. Change within 45min. after premedication.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

age from 3 months to 18 years

  • oral midazolam premedication for at least 30 minutes before rating
  • patient undergoing deep sedation / general anesthesia diagnostic or surgery with RASS -4 or more

Exclusion criteria

  • personal history of benzodiazepines using
  • moderate or severe respiratory insufficiency
  • myopathy, neuromuscular transmission disorders
  • moderate or severe CNS disability, including brain tumors, uncontrolled convulsions
  • age <3 months and> 18 years
  • pregnancy

Treatment and study plan

Primary outcomes

  1. Incidence of the paradoxical reaction in pediatric patients premedicated with oral midazolam prior to general anesthesia.

    Time frame: Change within 45min. after premedication

    Investigate the incidence of paradoxical reactions after administration of midazolam in the pediatric population

Sponsors and collaborators

Lead sponsor

Masaryk Hospital Usti nad Labem

Other

Registry information

Acronym: PARADOX

Important dates

Study start
2019
Primary completion
2021
Study completion
2021
First posted
Dec 9, 2019
Registry last updated
Oct 9, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.